Job ID 2019-5458

Overview

In the short-to-medium term the priorities of these two senior directors or executive directors Global Process Development are to:

  • Report to VP, Global Process Engineering and help to build each Global Process Development team in China of 10 staff this year which could grow rapidly over time
  • Work with US colleagues on platforms already under development for AAV and Lenti
  • Further grow the China Process & Technology Development organization, in a manner that is well coordinated with the Process & Technology Development (US) organization, for future technologies

Working location: Wuxi, China

Responsibilities

Key responsibilities:

  • Under the leader of VP of Global Process Engineering, co-development of global platforms, along with the US Product Development organization, with current focus on 3D platforms and viral vectors for the Advanced Therapies business: 
  • Partner with US Product Development, to develop platforms of cell lines and different manufacturing processes that are reproducible and scalable
  • Build out their organizations and organization skills so that their Global Product Development teams can work directly with global customers
  • Co-Develop platforms that can be licensed to customers for royalties and milestone payments
  • Participate in the development of global platforms and vector platforms that provide commercial scale production to customers, and more cost effective production for customers
  • Co-Develop platforms for cell or gene therapies, and produce cell lines where appropriate
  • Participate in the development of other key platforms in this area
  • Attend scientific conferences and represent WuXi to potential clients
  • Remain current on technologies to help maintain the organization’s long-term competitive position and profitability

Qualifications

Essential:

  • Ph.D. in pharmaceutical sciences, or a related field 
  • Experienced in viral and non-viral gene therapy product Process Development
  • Strong knowledge of cell culture techniques, gene therapy or cell therapy
  • Demonstrable evidence of building, developing and implementing Process Development systems in a systematic way
  • Experience of building and leading a group of senior scientists in Process Development
  • Technical Leader experience in multiple disciplines of science for Pharma and/or CRO business
  • Deep experience in bioreactors and cell line development 
  • Ability to build up quality yield from the upstream process
  • Fluent in English and Mandarin

Preferred:

  • Second line management experience 
  • Expertise in the field of vectors and/or vaccines

Key Attributes:

  • Able to work on multiple projects
  • Leadership  
  • Relationship building
  • Business acumen
  • Ability to influence in a matrixed environment

THE COMPANY

WuXi Advanced Therapies – Company Overview

The Advanced Therapies business unit of WuXi AppTec is a global Contract Development and Manufacturing Organization (CDMO) dedicated to accelerating and transforming development, manufacturing, and commercialization of cell, gene, and other advanced biopharmaceuticals.

Through continued internal reinvestment in facilities, technology, and talent combined with over three decades of biopharmaceutical testing expertise, WuXi Advanced Therapies have transformed their services for cell and gene therapy companies into solutions that alleviate industry bottlenecks, accelerate time to market, and support commercial programs around the world.

Serving clients that range from startup’s recently spun out of academic institutions, to large pharma companies seeking to launch a product in new markets, WuXi Advanced Therapies integrated development, manufacturing, and testing services provide tailored services that are ideal for:

  • Viral and non-viral Gene Therapies
  • Autologous and Allogeneic Cell Therapies
  • Gene Mediated and non-gene mediated Cell Therapies
  • Emerging technologies in cell gene therapy field like CRISPR/Cas9, NK cell, and Exosomes